Skip to main content

Breadcrumb

  1. Home

No risk adjustment or risk stratification

Intensive Care Unit Venous Thromboembolism Prophylaxis

  • This measure assesses the number of patients who received venous thromboembolism (VTE) prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after the initial admission (or transfer) to the Intensive Care Unit (ICU) or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer).

    CBE ID
    0372

Ischemic Vascular Disease (IVD): Blood Pressure Control

  • The percentage of patients 18 to 75 years of age who were discharged alive with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had the following during the measurement year:

    - Blood pressure control (BP): reported as under control <140/90 mm Hg.

    CBE ID
    0073

Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control &lt;100 mg/dL

  • The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to measurement year, who had each of the following during the measurement year.

    - Complete Lipid Profile
    - LDL-C control <100 mg/dL

    CBE ID
    0075

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

  • The percentage of patients 18 years of age and older who were discharged from an inpatient setting with an acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of routine use of aspirin or another antiplatelet during the measurement year.

    CBE ID
    0068

Laboratory Investigation for Secondary Causes of Fracture

  • Percentage of patients age 50 and over with fragility fracture who have had appropriate laboratory investigation for secondary causes of fracture ordered or performed prior to discharge from inpatient status.

    CBE ID
    2416